TrovaGene, Inc. (TROV) - Product Pipeline Analysis

GlobalData, November 2012, Pages: 42

Summary

TrovaGene, Inc. (TrovaGene), formally, Xenomics, Inc. is a development stage molecular diagnostic company. It is involved in the development of DNA-based tests with the use of transrenal DNA (Tr-DNA). The company uses its proprietary transrenal DNA test platform to develop highly sensitive, non-invasive molecular diagnostics. It has developed Tr-DNA diagnostic technology, which utilizes the fragmented DNA material that is available in urine to provide vital diagnostic information about conditions throughout the body. It also developed tests targeted at detecting and monitoring cancers and infectious diseases; as well as prenatal genetic tests for monitoring of organ and cell transplants. The company's patented technology has applications in tumor detection and monitoring, prenatal genetic testing, infectious diseases, tissue transplantation, forensic identification, and for patient selection in clinical trials. The company operates in the US. TrovaGene is headquartered in California, the US.

This report is a source for data, analysis and actionable intelligence on the TrovaGene, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.

List of Tables
List of Figures
TrovaGene, Inc. - Business Description
Key Facts
TrovaGene, Inc. - Major Products and Services
TrovaGene, Inc. Pipeline Products by Equipment Type
TrovaGene, Inc. Pipeline Products by Development Stage
TrovaGene, Inc. Pipeline Products by Therapy Area
TrovaGene, Inc. Pipeline Products by Milestone Summary
AML/NPM1 - Bone Marrow/Blood
AML/NPM1 - Bone Marrow/Blood Product Status
AML/NPM1 - Bone Marrow/Blood Product Description
AML/NPM1 - Bone Marrow/Blood Product Patent Details
Anti-TNF Panel Assay
Anti-TNF Panel Assay Product Status
Anti-TNF Panel Assay Product Description
Diagnostic Test - JC Virus
Diagnostic Test - JC Virus Product Status
Diagnostic Test - JC Virus Product Description
HPV Diagnostic Test - Men
HPV Diagnostic Test - Men Product Status
HPV Diagnostic Test - Men Product Description
HPV Diagnostic Test - Women
HPV Diagnostic Test - Women Product Status
HPV Diagnostic Test - Women Product Description
HPV Diagnostic Test - Women Product Milestone
HPV Diagnostic Test - Women Product Patent Details
K-RAS Assay - Pancreatic Cancer
K-RAS Assay - Pancreatic Cancer Product Status
K-RAS Assay - Pancreatic Cancer Product Description
Lyme Disease Assay
Lyme Disease Assay Product Status
Lyme Disease Assay Product Description
Next Generation CMOS Sensor Detection Platform
Next Generation CMOS Sensor Detection Platform Product Status
Next Generation CMOS Sensor Detection Platform Product Description
Non Invasive Prenatal Screening Test
Non Invasive Prenatal Screening Test Product Status
Non Invasive Prenatal Screening Test Product Description
TrovaGene, Inc. - Key Competitors
TrovaGene, Inc. - Key Employees
TrovaGene, Inc. - Key Employee Biographies
TrovaGene, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
TrovaGene, Inc., Recent Developments
Nov 14, 2012: Trovagene Reports Q3 2012 Results
Aug 15, 2012: Trovagene Reports Q2 2012 Results
Jul 18, 2012: Trovagene Announces Issuance Of US Patent For NPM Mutants To Diagnose And Monitor Acute Myeloid Leukemia
May 15, 2012: Trovagene Reports Q1 2012 Results
May 10, 2012: Trovagene Announces Issuance Of European Patent For Detection Of Pathogenic Infections
Mar 30, 2012: Trovagene Reports 2011 Results
Feb 27, 2012: Trovagene Partners With Leomics To Expand Business Development Activities
Feb 14, 2012: Trovagene Appoints Charlie Rodi As CTO
Feb 10, 2012: Trovagene Appoints Stephen Zaniboni As CFO
Dec 07, 2011: TrovaGene Appoints Antonius Schuh As CEO
Appendix
Methodology
About Us
Contact Us
Disclaimer

List of Tables
TrovaGene, Inc., Key Facts
TrovaGene, Inc. Key Pipeline Products by Equipment Type
TrovaGene, Inc. Key Pipeline Products by Therapy Area
TrovaGene, Inc. Key Pipeline Products by Development Stage
TrovaGene, Inc., Key Facts
TrovaGene, Inc., Major Products and Services
TrovaGene, Inc. Number of Pipeline Products by Equipment Type
TrovaGene, Inc. Pipeline Products by Equipment Type
TrovaGene, Inc. Number of Pipeline Products by Development Stage
TrovaGene, Inc. Pipeline Products by Development Stage
TrovaGene, Inc. Number of Pipeline Products by Therapy Area
TrovaGene, Inc. Pipeline Products by Therapy Area
TrovaGene, Inc. Number of Pipeline Products By Milestone Summary
TrovaGene, Inc. Pipeline Products by Milestone Summary
AML/NPM1 - Bone Marrow/Blood - Product Status
AML/NPM1 - Bone Marrow/Blood - Product Description
AML/NPM1 - Bone Marrow/Blood - Patent Details1
AML/NPM1 - Bone Marrow/Blood - Patent Details2
AML/NPM1 - Bone Marrow/Blood - Patent Details3
AML/NPM1 - Bone Marrow/Blood - Patent Details4
AML/NPM1 - Bone Marrow/Blood - Patent Details5
AML/NPM1 - Bone Marrow/Blood - Patent Details6
Anti-TNF Panel Assay - Product Status
Anti-TNF Panel Assay - Product Description
Diagnostic Test - JC Virus - Product Status
Diagnostic Test - JC Virus - Product Description
HPV Diagnostic Test - Men - Product Status
HPV Diagnostic Test - Men - Product Description
HPV Diagnostic Test - Women - Product Status
HPV Diagnostic Test - Women - Product Description
HPV Diagnostic Test - Women - Product Milestone
HPV Diagnostic Test - Women - Patent Details1
HPV Diagnostic Test - Women - Patent Details2
HPV Diagnostic Test - Women - Patent Details3
HPV Diagnostic Test - Women - Patent Details4
HPV Diagnostic Test - Women - Patent Details5
HPV Diagnostic Test - Women - Patent Details6
HPV Diagnostic Test - Women - Patent Details7
HPV Diagnostic Test - Women - Patent Details8
HPV Diagnostic Test - Women - Patent Details9
K-RAS Assay - Pancreatic Cancer - Product Status
K-RAS Assay - Pancreatic Cancer - Product Description
Lyme Disease Assay - Product Status
Lyme Disease Assay - Product Description
Next Generation CMOS Sensor Detection Platform - Product Status
Next Generation CMOS Sensor Detection Platform - Product Description
Non Invasive Prenatal Screening Test - Product Status
Non Invasive Prenatal Screening Test - Product Description
TrovaGene, Inc., Key Employees
TrovaGene, Inc., Key Employee Biographies
TrovaGene, Inc., Other Locations

List of Figures
TrovaGene, Inc. Key Pipeline Products by Equipment Type
TrovaGene, Inc. Pipeline Products by Equipment Type
TrovaGene, Inc. Pipeline Products by Development Stage
TrovaGene, Inc. Pipeline Products by Therapy Area
TrovaGene, Inc. Pipeline Products by Milestone Summary

Gen-Probe Incorporated
AmeriPath, Inc.
ImmTech, Inc
Guava Technologies, Inc.
Capricorn Products LLC.
Aphios Corporation
Teotten Diagnostics, Inc.
HX Diagnostics, Inc.
Maxim Biomedical, Inc.

Customers who bought this item also bought

• Top Five Global Electric Vehicle Companies: Performance, Strategies and Competitive Analysis
• Supplying Ford 2012
• Supplying Chrysler
• Ford Motor Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Global Automotive Head-up Display Market 2012-2016
• General Motors Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• American Tire Distributors Holdings, Inc. - Strategic SWOT Analysis Review
• Global Friction Products Market 2012-2016
• Supplying the Volkswagen Group
• American Axle & Manufacturing Holdings, Inc. (AXL) - Financial and Strategic SWOT Analysis Review